Wicher-Muniak E, Zmudka K, Dabroś W, Dudek D, Stachura J
Department of Clinical and Experimental Pathomorphology, Jagiellonian University Medical College, Kraków.
Pol J Pathol. 1997;48(1):69-74.
Functional and histological changes in skeletal muscle developing during hypolipemic therapy, especially with 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors are rare. This paper reports a case of simvastatin-induced myopathy confirmed histopathologically and ultrastructurally.